The Predictive Value of Sepsis Scores for In-Hospital Mortality in Patients with Left-Sided Infective Endocarditis

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
TROPICAL MEDICINE AND INFECTIOUS DISEASE, v.9, n.1, article ID 23, 10p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: As infective endocarditis has particular characteristics compared to other infectious diseases, it is not clear if sepsis scores are reported with good accuracy in these patients. The aim of this study is to evaluate the accuracy of the qSOFA and SOFA scores to predict mortality in patients with infective endocarditis. Methods: Between January 2010 and June 2019, 867 patients with suspected left-sided endocarditis were evaluated; 517 were included with left-sided infective endocarditis defined as ""possible"" or ""definite"" endocarditis, according to the Modified Duke Criteria. ROC curves were constructed to assess the accuracy of qSOFA and SOFA sepsis scores for the prediction of in-hospital mortality. Results: The median age was 57 years, 65% were male, 435 (84%) had pre-existing heart valve disease, and the overall mortality was 28%. The most frequent etiologies were Streptococcus spp. (36%), Enterococcus spp. (10%), and Staphylococcus aureus (9%). The sepsis scores from the ROC curves used to predict in-hospital mortality were qSOFA 0.601 (CI95% 0.522-0.681) and SOFA score 0.679 (CI95% 0.602-0.756). A sub-group analysis in patients with and without pre-existing valve disease for SOFA >= 2 showed ROC curves of 0.627 (CI95% 0.563-0.690) and 0.775 (CI95% 0.594-0.956), respectively. Conclusions: qSOFA and SOFA scores were associated with increased in-hospital mortality in patients with infective endocarditis. However, as accuracy was relatively lower compared to other sites of bacterial infections, we believe that this score may have lower accuracy when predicting the prognosis of patients with IE, because, in this disease, the patient's death may be more frequently linked to valvular and cardiac dysfunction, as well as embolic events, and less frequently directly associated with sepsis.
Palavras-chave
endocarditis, sepsis, SOFA, prognosis
Referências
  1. Asai N, 2019, J INFECT CHEMOTHER, V25, P965, DOI 10.1016/j.jiac.2019.05.014
  2. Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90
  3. Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7
  4. Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F
  5. Costa Mario Augusto Cray da, 2007, Rev Bras Cir Cardiovasc, V22, P192
  6. Damasco PV, 2014, INFECTION, V42, P835, DOI 10.1007/s15010-014-0640-2
  7. Donal Erwan, 2023, Eur Heart J Open, V3, poead064, DOI 10.1093/ehjopen/oead064
  8. Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]
  9. He PC, 2018, EUR J CLIN MICROBIOL, V37, P1243, DOI 10.1007/s10096-018-3240-8
  10. Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75
  11. Hoen B, 2013, NEW ENGL J MED, V369, P785, DOI 10.1056/NEJMc1307282
  12. Holland TL, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.59
  13. Khwannimit B, 2018, J CRIT CARE, V44, P156, DOI 10.1016/j.jcrc.2017.10.023
  14. Klein M, 2016, J INTENSIVE CARE MED, V31, P151, DOI 10.1177/0885066614554906
  15. Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753
  16. Manne MB, 2012, ANN THORAC SURG, V93, P489, DOI 10.1016/j.athoracsur.2011.10.063
  17. Marques A, 2020, ARQ BRAS CARDIOL, V114, P1, DOI 10.36660/abc.20180194
  18. Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603
  19. Nadji G, 2009, EUR J HEART FAIL, V11, P668, DOI 10.1093/eurjhf/hfp077
  20. Nappi F, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-4439
  21. Olmos C, 2013, EUR HEART J, V34, P1999, DOI 10.1093/eurheartj/ehs336
  22. Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328
  23. Ranzani OT, 2017, AM J RESP CRIT CARE, V196, P1287, DOI [10.1164/rccm.201611-2262OC, 10.1164/rccm.201611-2262oc]
  24. Rosa RG, 2017, BRAZ J INFECT DIS, V21, P665, DOI 10.1016/j.bjid.2017.09.002
  25. Samol A, 2015, INFECTION, V43, P287, DOI 10.1007/s15010-014-0715-0
  26. Serafim R, 2018, CHEST, V153, P646, DOI 10.1016/j.chest.2017.12.015
  27. Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287
  28. Slipczuk L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082665
  29. Songsangjinda T, 2020, MED INTENSIVA, V44, P226, DOI 10.1016/j.medin.2018.12.004
  30. Tamura Y, 2019, ACUTE MED SURG, V6, P138, DOI 10.1002/ams2.393
  31. Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1
  32. Werdan K, 2014, NAT REV CARDIOL, V11, P35, DOI 10.1038/nrcardio.2013.174